We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$20.3B
AUM Growth
+$1.22B
Cap. Flow
-$160M
Cap. Flow %
-0.79%
Top 10 Hldgs %
22.03%
Holding
1,796
New
121
Increased
266
Reduced
599
Closed
60

Top Buys

Rank Stock Value
1
TE
T1 Energy
TE
+$60.5M
2
PFE icon
Pfizer
PFE
+$44M
3
GXO icon
GXO Logistics
GXO
+$37.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$31.2M
5
JD icon
JD.com
JD
+$29.6M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$57.2M
2
BABA icon
Alibaba
BABA
+$57.2M
3
AMRC icon
Ameresco
AMRC
+$55.4M
4
SIVB
SVB Financial Group
SIVB
+$43.1M
5
WOLF icon
Wolfspeed
WOLF
+$41.1M

Sector Composition

Rank Sector Weight
1 Technology 25.22%
2 Healthcare 17.92%
3 Consumer Discretionary 13.84%
4 Financials 12.09%
5 Industrials 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEN.B icon
751
Lennar Class B
LEN.B
$20.7B
$1.37M 0.01%
15,064
-31,858
-68% -$2.62M
KRG icon
752
Kite Realty
KRG
$5.31B
$1.37M 0.01%
62,733
+34,208
+120% +$732K
AGNC icon
753
AGNC Investment
AGNC
$13B
$1.36M 0.01%
90,200
OMCL icon
754
Omnicell
OMCL
$1.72B
$1.36M 0.01%
7,523
-700
-9% -$121K
DXC icon
755
DXC Technology
DXC
$1.79B
$1.35M 0.01%
42,100
RNR icon
756
RenaissanceRe
RNR
$13.3B
$1.35M 0.01%
8,000
NTLA icon
757
Intellia Therapeutics
NTLA
$1.66B
$1.35M 0.01%
11,400
-2,600
-19% -$326K
RPRX icon
758
Royalty Pharma
RPRX
$26.1B
$1.35M 0.01%
33,800
PNFP icon
759
Pinnacle Financial Partners Inc
PNFP
$16.2B
$1.35M 0.01%
14,095
-1,100
-7% -$108K
STWD icon
760
Starwood Property Trust
STWD
$6.05B
$1.34M 0.01%
55,297
COUP
761
DELISTED
Coupa Software Incorporated
COUP
$1.34M 0.01%
8,499
-1,825
-18% -$376K
COLD icon
762
Americold
COLD
$4.32B
$1.34M 0.01%
40,900
AYI icon
763
Acuity Brands
AYI
$10.8B
$1.33M 0.01%
6,300
ARWR icon
764
Arrowhead Research
ARWR
$12.1B
$1.33M 0.01%
20,100
-400
-2% -$27.5K
NVST icon
765
Envista
NVST
$4.51B
$1.33M 0.01%
29,500
-1,400
-5% -$57.6K
LAD icon
766
Lithia Motors
LAD
$8.32B
$1.32M 0.01%
4,458
-100
-2% -$30.9K
FFIN icon
767
First Financial Bankshares
FFIN
$5.04B
$1.32M 0.01%
26,018
VNO icon
768
Vornado Realty Trust
VNO
$7.41B
$1.32M 0.01%
31,600
AGRO icon
769
Adecoagro
AGRO
$1.31B
$1.32M 0.01%
172,100
+4,700
+3% +$39.8K
MAT icon
770
Mattel
MAT
$4.25B
$1.32M 0.01%
61,300
NCLH icon
771
Norwegian Cruise Line
NCLH
$8.98B
$1.32M 0.01%
63,600
VOYA icon
772
Voya Financial
VOYA
$9.16B
$1.31M 0.01%
19,800
USFD icon
773
US Foods
USFD
$23.8B
$1.31M 0.01%
37,641
ASND icon
774
Ascendis Pharma A/S
ASND
$16.2B
$1.3M 0.01%
9,700
-900
-8% -$134K
CADE
775
DELISTED
Cadence Bank
CADE
$1.3M 0.01%
43,758
+21,898
+100% +$661K

Similar funds

Handelsbanken Fonder's Q4 2021 Portfolio in Review

As of Q4 2021, Handelsbanken Fonder held 1,796 positions worth $20.3B, up 6.4% from $19.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Handelsbanken Fonder's Q4 2021 filing shows 121 new, 266 increased, 599 reduced and 60 closed positions. Its largest new stake was T1 Energy: 5,589,851 shares worth $62.5M. The largest sale was NVIDIA, an estimated $57.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q4 2021 buy was T1 Energy: 5,589,851 shares worth $62.5M.
  • Handelsbanken Fonder added most to Pfizer in Q4 2021, an estimated $44M increase.
  • Handelsbanken Fonder's biggest Q4 2021 reduction was NVIDIA, cutting an estimated $57.2M.
  • Handelsbanken Fonder fully exited Acceleron Pharma in Q4 2021, selling an estimated $27.5M.
  • Handelsbanken Fonder's ten largest holdings make up 22% of its $20.3B portfolio in Q4 2021.
  • Handelsbanken Fonder opened 121 new positions and closed 60 in Q4 2021.
  • Handelsbanken Fonder's portfolio value rose 6.4% quarter-over-quarter to $20.3B.

Based on Handelsbanken Fonder's 13F filing for Q4 2021, filed 8 Feb 2022.